Antibiotic De-escalation in Onco-hematology Patients for Sepsis or Septic Shock
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cancer
- Critical Care
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
An interim analysis planned after inclusion of 233 patients. * Subgroup analyses will be performed on patient subsets: Patients with allogeneic HCST, Neutropenic patients (Neutrophils < 0.5 Giga/L), Hematological disease, Oncological disease, Polymicrobial sepsis, Multi-drug resistant organisms, Pat...
An interim analysis planned after inclusion of 233 patients. * Subgroup analyses will be performed on patient subsets: Patients with allogeneic HCST, Neutropenic patients (Neutrophils < 0.5 Giga/L), Hematological disease, Oncological disease, Polymicrobial sepsis, Multi-drug resistant organisms, Patients presenting with bacterial pneumoniae, Patients presenting with Intra-abdominal infection, Patients presenting with bacteraemia, Patients presenting with gram negative bacteria infection, Patients presenting with gram positive cocci infection, Patients presenting with septic shock, Patients presenting with sepsis.
Tracking Information
- NCT #
- NCT03683329
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: MOKART Djamel, MD Institut Paoli-Calmettes
Get Well Soon